Revolutionizing Healthcare: How Optum Real Transforms Claims

By Elena Pak, Credentialing Department, WCH

Central Thesis

Optum Real represents not merely an efficiency improvement in claims processing, but a fundamental restructuring of reimbursement power from post-claim human adjudication to pre-service algorithmic gatekeeping. This shift—marketed as reducing administrative friction—centralizes decision-making authority, creates asymmetric data advantages, and potentially transforms what providers can offer before care is delivered. For payer strategists, revenue cycle management leadership, and policy analysts, the critical question is not whether AI can process claims faster, but who controls the pre-service decision layer and how that control reshapes market dynamics in a consolidated industry.

I. The Structural Problem: Post-Facto Adjudication and Adversarial Architecture

1.1 Claims Processing as an Inherently Adversarial System

The U.S. healthcare reimbursement system operates on a post-facto adjudication model. Providers deliver care based on incomplete information about coverage, submit claims weeks or months later, and await payer decisions that may trigger multiple rounds of dispute resolution. This temporal disconnect creates structural adversarialism.

Quantifying the Administrative Burden: Methodological Considerations

Multiple data sources attempt to measure administrative costs, but attribution models vary significantly:

Premier Inc. survey (2024-2025): Self-reported data from hospitals indicating $25.7 billion in claims adjudication costs for 2023, up 23% from $19.7 billion in 2022. ¹
- Methodological note: Based on survey responses, not standardized cost accounting. Includes internal staff costs, external vendor fees, and technology investments attributed to claims management.
- Limitation: Does not separately quantify hospital costs vs. payer costs vs. third-party clearinghouse/RCM vendor spending.
American Hospital Association report (September 2024): Claims that administrative costs comprise “over 40% of hospital expenses” for some health systems. ²
- Methodological note: This figure aggregates multiple cost categories including regulatory compliance, quality reporting, EHR documentation, and claims processing—not solely claims adjudication.
- Limitation: The “40%” figure appears to reference outlier health systems, not the industry median.
Denial rates and overturn statistics: Industry estimates suggest 15% average denial rates, with approximately 70% of denied claims ultimately paid after appeal. ³
- Interpretation: High overturn rates indicate administrative friction rather than clinical necessity disputes, but these figures vary dramatically by payer (2%-49% range) and claim type.

Regulatory Context: Why Claims Cannot Be “Disrupted” Like Consumer Tech

Healthcare claims operate within a tightly regulated infrastructure that constrains innovation pathways:

X12 EDI Standards: HIPAA-mandated transaction sets (837 for claims submission, 835 for remittance advice, 278 for prior authorization) define data structure and exchange protocols. Any “real-time” system must either operate within these standards or obtain regulatory accommodation.
CMS Interoperability & Prior Authorization Final Rule (January 2024): Mandates that payers implement FHIR-based APIs for prior authorization and make decision-making criteria accessible to providers. ⁴ This creates a regulatory environment increasingly favorable to real-time data exchange, but also establishes baseline interoperability requirements that reduce proprietary advantage.
Information Blocking Rules (21st Century Cures Act): Prohibits practices that prevent or materially discourage access to electronic health information. Real-time claims platforms must navigate these requirements while potentially creating competitive moats through network effects.
No Surprises Act (NSA) Data Exchange Requirements: Mandates good-faith estimates and advanced explanation of benefits for certain services, creating regulatory precedent for pre-service cost transparency.

1.2 Why Traditional Automation Failed to Solve the Problem

Despite recognition of administrative waste, AI adoption in claims processing paradoxically declined from 62% of providers in 2022 to 31% in 2024. ⁵

Documented Barriers:

Lack of interoperability between payer and provider systems
Vendor fragmentation (multiple EHRs, clearinghouses, and payer platforms with incompatible data models)
High implementation costs relative to uncertain ROI for individual organizations
Regulatory compliance concerns about automated decision-making

II. Optum Real: Product Architecture and Strategic Positioning

2.1 Technical Architecture (Based on Available Public Information)

Optum Real is described as an AI-powered platform enabling real-time data exchange between payers and providers for pre-service coverage validation. ⁶ ⁷

What We Know (Public Statements):

Enables providers to query payer coverage rules in real-time before service delivery
Provides “specific coverage determinations” matching patient benefits, provider contracts, and clinical guidelines
Currently piloted with UnitedHealthcare (payer) and Allina Health (provider system)
Initial focus on outpatient radiology and cardiology claims
Processed over 5,000 patient visits during pilot phase

What We Do Not Know (Critical Technical Gaps):

Decision Logic Architecture: Is this a rules engine with ML-based optimization, or does it employ large language models for clinical guideline interpretation? The distinction matters for liability, auditability, and regulatory compliance.
Deterministic vs. Probabilistic Outputs: Does the system provide binary coverage decisions, or probabilistic recommendations requiring human review?
Liability Framework: If real-time validation indicates coverage, but post-service adjudication results in denial, who bears financial risk?
API Standards: Does the platform use FHIR-based APIs (as required by CMS for prior authorization), or proprietary interfaces?
Training Data Provenance: What claims data trains the AI models, and how does Optum handle potential bias from historical denial patterns?

2.2 Pilot Program Results: Fact vs. Marketing Claims

Reported Outcomes (sourced from Optum/Allina Health public statements):

25% reduction in call volume at one provider site within two weeks ⁸
42% decrease in call volume at another provider site ⁸
Up to 75% reduction in reimbursement submission errors at a Minnesota health system ⁸
Dave Ingham (Allina Health CIO): “reduced administrative errors and improved patient experience” ⁷

Methodological Questions for Evaluating These Claims:

Baseline comparison: Were these reductions measured against historical averages, or against a control group?
Selection bias: Radiology and cardiology outpatient claims may be simpler/more standardized than surgical, emergency, or multi-procedure encounters.
Temporal effects: Do two-week metrics reflect sustainable improvement or initial novelty/learning curve effects?
Error attribution: What percentage of “submission errors” were data quality issues (e.g., incorrect patient information) vs. coverage rule misinterpretation?

2.3 The “Chicken-and-Egg” Network Effect: Strategy vs. Rhetoric

Puneet Maheshwari (SVP, Optum Real) describes the adoption challenge as “a two-sided, chicken-and-egg problem in a hyperlocal market.” ⁹ Providers need payer participation; payers need provider adoption.

Fact: Multi-sided platforms face cold-start problems requiring coordination across interdependent actors.

Strategic Context: UnitedHealthcare’s participation as the anchor payer is not merely operational convenience—it is a deliberate strategy to leverage UnitedHealth Group’s vertical integration.

Market Position Analysis:

UnitedHealth Group serves 9 out of 10 U.S. health systems and 4 out of 5 payers through Optum subsidiaries ⁹
UnitedHealthcare is the largest private insurer by membership
Optum owns Change Healthcare (claims clearinghouse processing ~15 billion transactions annually before the 2024 cyberattack)
Optum Health employs/affiliates with approximately 90,000 physicians

III. The Strategic Fork: Cooperative vs. Adversarial AI Ecosystems

3.1 The AI Arms Race Scenario

Maheshwari warns: “Today, it’s my rule-based system against your rule-based system. Tomorrow, it’s going to be my AI versus your AI.” ⁹

What This Means in Practice:

Scenario A: Adversarial AI Escalation

Providers deploy AI to optimize claim coding for maximum reimbursement
Payers deploy AI to identify documentation gaps, unbundling opportunities, and denial triggers
Both sides invest in increasingly sophisticated models to outmaneuver the other
Administrative costs shift from manual review to AI development/deployment, but total burden does not decrease
Claims decisions become opaque algorithmic outputs, reducing transparency and accountability

Scenario B: Cooperative AI Platform (Optum Real’s Value Proposition)

Single shared platform with unified decision logic
Providers and payers operate from the same coverage rules and data
AI reduces information asymmetry rather than exploiting it
Administrative costs genuinely decline because disputes are resolved pre-service

Critical Question: Why would rational actors choose Scenario B when Scenario A preserves competitive positioning and revenue optimization opportunities?

3.2 Data Moats and Asymmetric Intelligence

The Strategic Value of Claims Visibility

Real-time claims validation creates data exhaust with strategic value beyond operational efficiency:

Treatment Pattern Intelligence: Aggregated pre-service queries reveal what providers are considering offering, not just what they ultimately deliver. This provides earlier signals about utilization trends.
Network Steering: If the platform provides differential coverage guidance based on in-network vs. out-of-network providers, it functions as a quasi-utilization management layer before patients schedule appointments.
Contract Negotiation Leverage: Payers operating the platform gain visibility into provider cost structures and service mix before negotiating rates.
Predictive Risk Modeling: Pre-service data enables more accurate medical cost trend forecasting than claims lag allows.

3.3 The Regulatory Wildcards

CMS Policies That Could Accelerate or Constrain Optum Real:

Prior Authorization Requirements for Medicare Advantage: CMS has signaled increased scrutiny of MA plan denials and announced plans to expand audits and invest in medical coding workforce. ¹⁰ If CMS mandates real-time prior authorization validation using FHIR APIs, it creates regulatory tailwind for platforms like Optum Real.
Interoperability Enforcement: If CMS strictly enforces FHIR API requirements and information blocking rules, it reduces proprietary platform advantages and enables competitive alternatives to emerge.
Antitrust Scrutiny: DOJ and FTC have increased focus on healthcare market concentration. If regulators view Optum Real as leveraging UnitedHealth Group’s vertical integration to foreclose competition, they could impose structural remedies (e.g., data access requirements, non-discrimination rules).

IV. What This Means for Payer Strategy, RCM Leadership, and Policy Analysts

4.1 For Payer Strategists

Decision Framework:

If you are a competing payer considering Optum Real adoption:

Benefits:

Reduced administrative costs from fewer calls, faster adjudication, lower error rates
Improved provider relations through reduced friction
Potential network access to Optum-affiliated providers who standardize on the platform

Risks:

Data asymmetry: Optum/UnitedHealthcare gain visibility into your coverage rules, denial patterns, and utilization trends
Strategic dependency: Adopting a competitor-controlled platform creates switching costs and vendor lock-in
Market signaling: Your participation validates UnitedHealth Group’s platform strategy and may accelerate consolidation

Alternative Strategy: Invest in industry consortia developing open-source or multi-payer governance models for real-time adjudication (e.g., CARIN Alliance, Da Vinci Project FHIR implementations).

4.2 For RCM Leadership

If you lead revenue cycle operations at a health system:

Benefits of Early Adoption:

Tangible reduction in denied claims, rework, and collections costs
Improved cash flow from faster payment certainty
Staff redeployment from administrative tasks to higher-value activities (e.g., complex case review, patient financial counseling)

Implementation Considerations:

Integration with existing EHR, practice management, and scheduling systems
Change management and workflow redesign (training clinical staff to query coverage before ordering)
Contract terms: Is this a subscription model? Per-transaction fee? How are costs allocated?
Data governance: What patient/provider data does Optum retain? Can it be used for other UnitedHealth Group business lines?

Strategic Question: Does Optum Real reduce your dependency on multi-payer complexity, or increase your dependency on UnitedHealth Group infrastructure?

4.3 For Policy Analysts

Key Policy Questions:

Should pre-service algorithmic validation be regulated like prior authorization? If AI platforms make binding coverage determinations before care delivery, do they require the same transparency, appeal rights, and clinical oversight as traditional PA?
What is the optimal level of standardization? Should CMS mandate standardized coverage decision APIs (like FHIR for interoperability), or allow proprietary platforms to compete?
How do we prevent the AI arms race? If cooperative platforms fail to achieve scale, and adversarial AI escalation occurs, what policy interventions could mandate alignment?
What is the antitrust threshold for vertical integration in data infrastructure? When does a payer-owned claims platform become anticompetitive, and what remedies (data portability, non-discrimination, structural separation) are appropriate?

V. Conclusion: Efficiency Gains vs. Power Centralization

Optum Real delivers measurable operational improvements: fewer errors, faster decisions, reduced administrative burden. These benefits are real and significant for providers drowning in administrative complexity.

But the strategic significance extends beyond operational efficiency. Pre-service algorithmic validation centralizes reimbursement power in the entity that controls the decision layer. If UnitedHealth Group—already the dominant player across insurance, provider services, pharmacy benefits, and claims infrastructure—operates the platform that determines what providers can offer before care delivery, it compounds information asymmetry and market concentration in ways that operational efficiency metrics do not capture.

The critical decision for payers, providers, and policymakers is not whether AI can improve claims processing (it clearly can), but whether the improvement should occur through proprietary platforms controlled by vertically integrated conglomerates or through open, interoperable standards that distribute power more evenly across the ecosystem.

This is not a technical question. It is a structural question about who controls the rules of the healthcare marketplace.

If you found this article valuable, our monthly newsletter goes even deeper—with exclusive compliance strategies, advanced coding guidance, and insider insights you won’t find anywhere else. Subscribe to access what matters most.

Sources

Premier Inc. (August 19, 2025). “Claims Adjudication Costs Providers $25.7 Billion – $18 Billion is Potentially Unnecessary Expense.” Survey of hospital and health system members, based on self-reported cost data. Available at: https://premierinc.com/newsroom/policy/claims-adjudication-costs-providers-257-billion-18-billion-is-potentially-unnecessary-expense
American Hospital Association. (September 10, 2024). “Skyrocketing Hospital Administrative Costs, Burdensome Commercial Insurer Policies Impacting Patient Care.” Report aggregating multiple cost categories; “40%” figure references outlier systems. Available at: https://www.aha.org/guidesreports/2024-09-10-skyrocketing-hospital-administrative-costs-burdensome-commercial-insurer-policies-are-impacting
Experian Health. (October 10, 2025). “Healthcare claim denial statistics: State of Claims Report 2025.” Industry survey data; denial rates vary 2%-49% by payer. Available at: https://www.experian.com/blogs/healthcare/healthcare-claim-denials-statistics-state-of-claims-report/
Centers for Medicare & Medicaid Services. (January 2024). “CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F).” Federal Register. Mandates FHIR-based APIs for prior authorization by January 1, 2026.
Aptarro. (December 23, 2025). “50+ US Healthcare Denial Rates & Reimbursement Statistics for 2026.” Cites decline in AI adoption from 62% (2022) to 31% (2024) based on CAQH Index data. Available at: https://www.aptarro.com/insights/us-healthcare-denial-rates-reimbursement-statistics
Fierce Healthcare. (October 22, 2025). “HLTH25: Optum unveils new AI-powered claims processing platform.” Conference announcement and product positioning. Available at: https://www.fiercehealthcare.com/payers/hlth25-optum-unveils-new-ai-powered-claims-processing-platform
Healthcare Dive. (October 22, 2025). “Optum launches AI system to speed medical claims.” Includes Dave Ingham (Allina Health CIO) statements. Available at: https://www.healthcaredive.com/news/optum-real-ai-speed-claims-review-united-health/803448/
Digital Health News. (2025). “Optum pilots AI-led claims solution to ease healthcare administration.” Reports pilot metrics (25%, 42%, 75% reductions). Available at: https://www.digitalhealthnews.com/optum-unveils-ai-platform-to-streamline-claims-processing
Becker’s Payer Issues. (October 22, 2025). “Optum launches AI-powered claims system ‘to eliminate complexity and administrative waste.'” Includes Puneet Maheshwari quotes. Available at: https://www.beckerspayer.com/payer/optum-leans-on-ai-powered-claims-system-to-eliminate-complexity-and-administrative-waste
Centers for Medicare & Medicaid Services. (2025). Press releases on Medicare Advantage audit expansion and prior authorization oversight. Referenced in multiple trade publications including Healthcare Dive and Fierce Healthcare.

Note on Methodology: This analysis distinguishes between verifiable facts (sourced data, regulatory requirements, public company statements) and author interpretation (strategic implications, market dynamics, policy recommendations). Readers should evaluate interpretive claims independently based on their organizational context and strategic objectives.

This is an independent analysis based on publicly available information. Views are the author’s and not legal or investment advice.